Join the club for FREE to access the whole archive and other member benefits.

Senolytic Therapeutics (Senolytx)

Pharmaceutical company that develops a novel class of medicines by targeting damaged cells.

Senolytic Therapeutics is a operator of a pharmaceutical company intended to develop medicines and therapeutics for patients affected by age-related diseases. The company's medicines target and eliminate damaged cells, enabling healthcare providers to improve the lives of those affected by diseases associated with aging.

Visit website:

People at Senolytic Therapeutics (Senolytx)

Company Representative
Timothy (Tim) Cash
- Chief Scientific Officer at Senolytic Therapeutics.

Senolytic Therapeutics (Senolytx) News

Labiotech gathers feedback from European biotechs on Unity failure

Labiotech - 28-Aug-2020

General feeling that failures are bound to happen - but that their approaches can succeed


LEAF report from the Longevity Leaders Conference

Life Extension Advocacy Foundation (LEAF) - 06-Feb-2019

Encouraging signs from big companies - more interviews to follow